Improvement of sexual arousal, sexual desire, orgasm and/or pleasure following intravaginal prasterone (dhea) administration in women not suffering or independently from dyspareunia or other symptoms of vulvo-vaginal atrophy
Improvement of sexual arousal, sexual desire, orgasm and/or pleasure following intravaginal prasterone (dhea) administration in women not suffering or independently from dyspareunia or other symptoms of vulvo-vaginal atrophy
- CN 104,540,511 A
- Filed: 07/19/2013
- Published: 04/22/2015
- Est. Priority Date: 07/25/2012
- Status: Active Application
- EN CH
-
- Pin
